Cargando…
Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
BACKGROUND: The prognosis of patients with advanced biliary tract cancer (BTC) is extremely poor and only a few standard treatments are available for this condition. We performed a phase I trial to investigate the safety, immune response and anti-tumor effect of vaccination with three peptides deriv...
Autores principales: | Aruga, Atsushi, Takeshita, Nobuhiro, Kotera, Yoshihito, Okuyama, Ryuji, Matsushita, Norimasa, Ohta, Takehiro, Takeda, Kazuyoshi, Yamamoto, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015445/ https://www.ncbi.nlm.nih.gov/pubmed/24606884 http://dx.doi.org/10.1186/1479-5876-12-61 |
Ejemplares similares
-
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
por: Okuyama, Ryuji, et al.
Publicado: (2013) -
Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
por: Aruga, Atsushi
Publicado: (2013) -
RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer
por: Matsushita, Norimasa, et al.
Publicado: (2017) -
Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008) -
Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)